{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:24:34Z","timestamp":1770513874032,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Novavax Inc."}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vaccine.2017.02.012","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T17:46:10Z","timestamp":1487871970000},"page":"1586-1589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["MERS-CoV spike nanoparticles protect mice from MERS-CoV infection"],"prefix":"10.1016","volume":"35","author":[{"given":"Christopher M.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiagarajan","family":"Venkataraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye V.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gale E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Flyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew B.","family":"Frieman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.02.012_b0005","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Eng J Med"},{"key":"10.1016\/j.vaccine.2017.02.012_b0010","doi-asserted-by":"crossref","DOI":"10.3201\/eid2207.160022","article-title":"Development of medical countermeasures to Middle East respiratory syndrome coronavirus","volume":"22","author":"Uyeki","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.012_b0015","doi-asserted-by":"crossref","DOI":"10.3201\/eid2208.160229","article-title":"Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14\u201315, 2015","volume":"22","author":"Excler","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.012_b0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.02.012_b0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2016.07.015","article-title":"MERS-CoV spike protein: targets for vaccines and therapeutics","volume":"133","author":"Wang","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2017.02.012_b0030","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.012_b0035","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1099\/vir.0.060640-0","article-title":"Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus","volume":"95","author":"Coleman","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.02.012_b0040","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1128\/JVI.03764-13","article-title":"Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection","volume":"88","author":"Cockrell","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.02.012_b0045","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1128\/JVI.03445-14","article-title":"Glycosylation of mouse DPP4 plays a role in inhibiting Middle East respiratory syndrome coronavirus infection","volume":"89","author":"Peck","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.02.012_b0050","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.02.012_b0055","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/infdis\/jiv325","article-title":"Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection","volume":"212","author":"Channappanavar","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.012_b0060","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.02.012_b0065","doi-asserted-by":"crossref","first-page":"326ra21","DOI":"10.1126\/scitranslmed.aaf1061","article-title":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo","volume":"8","author":"Luke","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2017.02.012_b0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/cmi.2015.03","article-title":"Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus","volume":"13","author":"Zhang","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2017.02.012_b0075","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/cr.2015.113","article-title":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res"},{"key":"10.1016\/j.vaccine.2017.02.012_b0080","article-title":"One-health: a safe, efficient dual-use vaccine for humans and animals against MERS-CoV and Rabies virus","author":"Wirblich","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.02.012_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc15e02s37","article-title":"Growth and quantification of MERS-CoV infection","volume":"37","author":"Coleman","year":"2015","journal-title":"Curr Protoc Microbiol"},{"key":"10.1016\/j.vaccine.2017.02.012_b0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1586\/erv.11.25","article-title":"ISCOM technology-based Matrix M adjuvant: success in future vaccines relies on formulation","volume":"10","author":"Lovgren Bengtsson","year":"2011","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.vaccine.2017.02.012_b0095","doi-asserted-by":"crossref","first-page":"e50852","DOI":"10.1371\/journal.pone.0050852","article-title":"Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats","volume":"7","author":"Smith","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T04:09:24Z","timestamp":1549771764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17301937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0264410X17301937"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MERS-CoV spike nanoparticles protect mice from MERS-CoV infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}